239 related articles for article (PubMed ID: 7809504)
1. Pathology of neuroblastic tumors.
Joshi VV; Silverman JF
Semin Diagn Pathol; 1994 May; 11(2):107-17. PubMed ID: 7809504
[TBL] [Abstract][Full Text] [Related]
2. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B
Cancer; 1999 Jul; 86(2):349-63. PubMed ID: 10421272
[TBL] [Abstract][Full Text] [Related]
3. The International Neuroblastoma Pathology Classification (the Shimada system).
Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B; Stram DO; Gerbing RB; Lukens JN; Matthay KK; Castleberry RP
Cancer; 1999 Jul; 86(2):364-72. PubMed ID: 10421273
[TBL] [Abstract][Full Text] [Related]
4. Conventional versus modified morphologic criteria for ganglioneuroblastoma. A review of cases from the Pediatric Oncology Group.
Joshi VV; Cantor AB; Altshuler G; Cohen LJ; Larkin EW; Shuster JJ; Rao PV; Holbrook CT; Hayes FA; Castleberry RP
Arch Pathol Lab Med; 1996 Sep; 120(9):859-65. PubMed ID: 9140292
[TBL] [Abstract][Full Text] [Related]
5. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.
Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; Shay JW; Gazdar AF
Cancer; 1999 Feb; 85(3):741-9. PubMed ID: 10091748
[TBL] [Abstract][Full Text] [Related]
6. [Peripheral neuroblastic tumors: anatomo pathological classification].
Peuchmaur M
Ann Pathol; 2004 Dec; 24(6):556-67. PubMed ID: 15785402
[TBL] [Abstract][Full Text] [Related]
7. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
[TBL] [Abstract][Full Text] [Related]
8. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathologic features of peripheral neuroblastic tumors].
Yang BF; Fu LB; He LJ
Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):305-10. PubMed ID: 24004586
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal peptide and its relationship to ganglion cell differentiation in neuroblastic tumors.
Mendelsohn G; Eggleston JC; Olson JL; Said SI; Baylin SB
Lab Invest; 1979 Aug; 41(2):144-9. PubMed ID: 222958
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between typing of peripheral neuroblastic tumors and prognosis: a clinicopathologic study of 135 cases].
YIN MZ; ZHANG ZD; MA J; SHEN P; CHEN JF; ZHANG HZ
Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):151-5. PubMed ID: 21575383
[TBL] [Abstract][Full Text] [Related]
12. Tumors of the neuroblastoma group.
Shimada H
Pathology (Phila); 1993; 2(1):43-59. PubMed ID: 9420930
[TBL] [Abstract][Full Text] [Related]
13. Comparison of ultrastructural features among neuroblastic tumors: maturation from neuroblastoma to ganglioneuroma.
Hicks MJ; Mackay B
Ultrastruct Pathol; 1995; 19(4):311-22. PubMed ID: 7571090
[TBL] [Abstract][Full Text] [Related]
14. The neuroendocrine and neural profiles of neuroblastomas, ganglioneuroblastomas, and ganglioneuromas.
Molenaar WM; Baker DL; Pleasure D; Lee VM; Trojanowski JQ
Am J Pathol; 1990 Feb; 136(2):375-82. PubMed ID: 1689542
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
Krajewski S; Chatten J; Hanada M; Reed JC
Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the Pediatric Oncology Group.
Joshi VV; Cantor AB; Altshuler G; Larkin EW; Neill JS; Shuster JJ; Holbrook CT; Hayes FA; Castleberry RP
Cancer; 1992 Apr; 69(8):2183-96. PubMed ID: 1544124
[TBL] [Abstract][Full Text] [Related]
17. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
18. Divergent differentiation in neuroendocrine tumors of the adrenal gland.
Tischler AS
Semin Diagn Pathol; 2000 May; 17(2):120-6. PubMed ID: 10839612
[TBL] [Abstract][Full Text] [Related]
19. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
[TBL] [Abstract][Full Text] [Related]
20. Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.
Peuchmaur M; d'Amore ES; Joshi VV; Hata J; Roald B; Dehner LP; Gerbing RB; Stram DO; Lukens JN; Matthay KK; Shimada H
Cancer; 2003 Nov; 98(10):2274-81. PubMed ID: 14601099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
